Status:
RECRUITING
Evaluation of Circulating Neutrophils in Antisynthetase Syndrome
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Antisynthetase Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Antisynthetase syndrome (ASyS) is a rare and heteregeneous overlapping connective tissue disease, characterized by myositis, interstitial lung disease (ILD), joint involvement, Raynaud's phenomenon an...
Eligibility Criteria
Inclusion
- Patients with ASyS diagnosis according to Connors criteria
Exclusion
- Active infection at ASyS diagnosis
- Evolutive cancer at ASyS diagnosis
- Corticosteroid therapy initiation before circulating neutrophils evaluation
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05989399
Start Date
January 1 2024
End Date
October 31 2025
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nancy
Nancy, France